These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 566868)
1. Lergotrile in the treatment of parkinsonism. Klawans HL; Goetz CG; Volkman P; Nausieda PA; Weiner WJ Neurology; 1978 Jul; 28(7):699-702. PubMed ID: 566868 [TBL] [Abstract][Full Text] [Related]
2. Comparison between lergotrile and bromocriptine in parkinsonism. Teychenne PF; Pfeiffer RF; Bern SM; McInturff D; Calne DB Ann Neurol; 1978 Apr; 3(4):319-24. PubMed ID: 666273 [TBL] [Abstract][Full Text] [Related]
3. Studies on the antiparkinsonism efficacy of lergotrile. Lieberman A; Miyamoto T; Battista AF; Goldstein M Neurology; 1975 May; 25(5):459-62. PubMed ID: 166332 [TBL] [Abstract][Full Text] [Related]
4. Treatment of Parkinson's disease with lergotrile mesylate. Lieberman A; Estey E; Kupersmith M; Gopinathan G; Goldstein M JAMA; 1977 Nov; 238(22):2380-2. PubMed ID: 335094 [TBL] [Abstract][Full Text] [Related]
5. Paradoxial response to dopaminergic agents in parkinsonism. Wiener WJ; Kramer J; Nausieda PA; Klawans HL Arch Neurol; 1978 Jul; 35(7):453-5. PubMed ID: 666596 [TBL] [Abstract][Full Text] [Related]
6. Lergotrile in Parkinson disease: further studies. Lieberman AN; Gopinathan G; Estey E; Kupersmith M; Goodgold A; Goldstein M Neurology; 1979 Feb; 29(2):267-72. PubMed ID: 34808 [TBL] [Abstract][Full Text] [Related]
7. Treatment of Parkinson's disease with dopamine agonists: a review. Lieberman A; Neophytides A; Kupersmith M; Casson I; Durso R; Foo SH; Khayali M; Tartaro T; Goldstein M Am J Med Sci; 1979; 278(1):65-76. PubMed ID: 39452 [TBL] [Abstract][Full Text] [Related]
8. Lergotrile in Parkinson's disease. Lieberman AN; Kupersmith M; Estey E; Goldstein M Lancet; 1976 Sep; 1(7984):515-6. PubMed ID: 74475 [No Abstract] [Full Text] [Related]
9. Cross tolerance between two dopaminergic ergot derivatives--bromocriptine and lergotrile. Teychenne PF; Rosin AJ; Plotkin CN; Calne DB Br J Clin Pharmacol; 1980 Jan; 9(1):47-50. PubMed ID: 6101955 [TBL] [Abstract][Full Text] [Related]
10. Role of ergot derivatives in the treatment of parkinsonism. Calne DB Fed Proc; 1978 Jun; 37(8):2207-9. PubMed ID: 658459 [No Abstract] [Full Text] [Related]
11. The treatment of hyperprolactinemia with a new ergot derivative, lergotrile mesylate. Sherman BM; Swanson JA; Chapler FK Fertil Steril; 1978 Mar; 29(3):291-5. PubMed ID: 565303 [TBL] [Abstract][Full Text] [Related]
12. Comparative efficacy of two dopamine agonists, pergolide and lergotrile, in Parkinson disease. Lieberman AN; Goldstein M; Leibowitz M N Y State J Med; 1988 Aug; 88(8):420-2. PubMed ID: 2902541 [No Abstract] [Full Text] [Related]